Anacor Pharmaceuticals, Inc. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 0.00 | 6,350 | 0 | 6,350 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 37.81 | 24,360 | 921,052 | 24,360 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Grant | A | 0.00 | 5,865 | 0 | 28,156 | 22.3 K to 28.2 K (+26.31 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | A | 0.00 | 6,350 | 0 | 6,350 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | A | 37.81 | 24,360 | 921,052 | 24,360 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Grant | A | 0.00 | 5,865 | 0 | 30,865 | 25 K to 30.9 K (+23.46 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Grant | A | 0.00 | 5,020 | 0 | 13,020 | 8 K to 13 K (+62.75 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Grant | A | 0.00 | 5,020 | 0 | 5,020 | 0 to 5 K |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Grant | A | 0.00 | 5,020 | 0 | 9,620 | 4.6 K to 9.6 K (+109.13 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Grant | A | 0.00 | 5,020 | 0 | 29,087 | 24.1 K to 29.1 K (+20.86 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Option Exercise | A | 0.00 | 6,930 | 0 | 6,930 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Option Exercise | A | 37.81 | 28,400 | 1,073,804 | 28,400 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Grant | A | 0.00 | 6,840 | 0 | 94,840 | 88 K to 94.8 K (+7.77 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 6,930 | 0 | 6,930 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | A | 37.81 | 28,400 | 1,073,804 | 28,400 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Grant | A | 0.00 | 6,840 | 0 | 79,603 | 72.8 K to 79.6 K (+9.40 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 0.00 | 12,890 | 0 | 12,890 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 37.81 | 84,100 | 3,179,821 | 84,100 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Grant | A | 0.00 | 20,260 | 0 | 346,260 | 326 K to 346.3 K (+6.21 %) |
| Feb 04 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 37.41 | 600 | 22,448 | 4,600 | 5.2 K to 4.6 K (-11.54 %) |
| Feb 04 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 37.35 | 6,875 | 256,781 | 51,475 | 58.4 K to 51.5 K (-11.78 %) |